TABLE 2.
Ligands | [125I]CCL4 |
Gαi1 |
Gαob |
Gα12 |
β-Arr2 |
cAMP |
Ca2+ |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pIC50 | pKi | pEC50 | Emax | pEC50 | Emax | pEC50 | Emax | pEC50 | Emax | pEC50 | Emax | pEC50 | Emax | |
CCL3 | −8.7 ± 0.1 | −8.9 ± 0.1 | −8.1 ± 0.4 | −0.09 ± 0.02 | −8.1 ± 0.4 | −0.08 ± 0.02 | −8.6 ± 0.3 | −0.017 ± 0.002 | −8.6 ± 0.2 | 0.08 ± 0.01 | −10.6 ± 0.2 | 43 ± 3 | −7.2 ± 0.1 | 119 ± 12 |
CCL4 | −9.2 ± 0.1 | −9.4 ± 0.1 | −8.5 ± 0.2 | −0.07 ± 0.02 | −8.3 ± 0.2 | −0.10 ± 0.01 | −8.1 ± 0.2 | −0.016 ± 0.002 | −8.1 ± 0.1 | 0.10 ± 0.01 | −9.1 ± 0.1 | 44 ± 3 | −8.2 ± 0.2 | 75 ± 5 |
CCL5 | −8.2 ± 0.1 | −8.4 ± 0.1 | −9.1 ± 0.5 | −0.09 ± 0.02 | −9.2 ± 0.1 | −0.10 ± 0.01 | −9.0 ± 0.3 | −0.020 ± 0.001 | −8.1 ± 0.2 | 0.10 ± 0.01 | −10.3 ± 0.3 | 34 ± 2 | −8.0 ± 0.2 | 91 ± 3 |
CCL8 | −8.2 ± 0.1 | −8.4 ± 0.1 | −8.2 ± 0.1 | −0.09 ± 0.01 | −8.1 ± 0.3 | −0.06 ± 0.01 | −8.1 ± 0.4 | −0.015 ± 0.003 | −7.0 ± 0.2 | 0.08 ± 0.01 | −9.2 ± 0.2 | 39 ± 3 | −7.4 ± 0.1 | 89 ± 3 |
CCL13 | −7.2 ± 0.1 | −7.4 ± 0.1 | ND | ND | −7.6 ± 0.1 | −0.05 ± 0.01 | ND | ND | ND | ND | ND | ND | ND | ND |